Created in 2011 (Denmark), Galecto Biotech own 496 sister brands and 17477 competing brands. Galecto Biotech's notoriety arose from exemplary management which optimizes product quality and client satisfaction, which in turn generate financial performance, and therefore, stock performance. Being a Popular brand online is assessed based on the evolution of worldwide Web searches over the last five years.

Galecto Biotech is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Popularity

Buy BRISTOL-MYERS SQUIBB COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
The following interest graph for Galecto Biotech shows the evolution of worldwide Web searches in the last five years. The graph shows the evolution of Galecto Biotech search rates over time, with a value of 100 indicating the month when it was highest.
Evolution of interest in the search “Galecto Biotech” (Google Trends)
Sources: Google Trends and Allbrands.markets
Compare the 5-year Web notoriety graph with the 5-year market price graph:
Notoriety -> Market prices